ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "population studies"

  • Abstract Number: 2022 • ACR Convergence 2024

    Could Initiation of Sodium Glucose Co-Transporter-2 Inhibitors Reduce the Need for Conventional Urate-Lowering Therapy and Flare Medications in Patients with Gout?Population-Based Target Trial Emulation Studies

    Natalie McCormick1, Chio Yokose2, Leo Lu3, Sharan Rai1, Gregory Challener1 and Hyon K. Choi4, 1Massachusetts General Hospital, Boston, MA, 2Massachusetts General Hospital, Waltham, MA, 3Arthritis Research Canada, Vancouver, BC, Canada, 4Massachusetts General Hospital, Lexington, MA

    Background/Purpose: Sodium-glucose cotransporter-2 inhibitors (SGLT2i) lower serum urate levels and are associated with reduced risk of incident gout as well as recurrent flares [Annals IM…
  • Abstract Number: 0144 • ACR Convergence 2024

    More Than a Monolith: Disaggregating Rheumatoid Arthritis Prevalence Among Asian American Subgroups

    John Chen1, Tanya Selvam1, Jeanne Darbinian2, Christopher Macko1, Nirmala Ramalingam2, Joan Lo2 and Lucy Liu2, 1Kaiser Permanente Oakland Medical Center, Oakland, CA, 2Kaiser Permanente, Oakland, CA

    Background/Purpose: Rheumatoid arthritis (RA) is a disabling, autoimmune condition affecting up to as many as 17.6 million individuals worldwide. Epidemiologic evidence in the United States…
  • Abstract Number: 2054 • ACR Convergence 2024

    Phenotypical Differences in VEXAS Syndrome, Where Are We a Year Later? Results from a National Cohort Focused on Rheumatological Patients

    Paula García Escudero1, Marta López I Gómez2, Berta Magallanes López3, Diego Dios Santos4, Francisco Javier Toyos Sáenz de Miera5, Alicia García Dorta6, José Ángel Hernández Beriain7, Íñigo Rúa-Figueroa8, cristiana sieiro santos9, Elvira Díez Álvarez10, Marta Ibáñez Martínez11, Beatriz Frade-Sosa12, Judit Font Urgelles13, Meritxell Sallés Lizarzaburu14, Elena Riera Alonso15, Ernesto Trallero Araguás16, Eugenia Enríquez Merayo17, Maria Rodriguez-Laguna18, irene monjo19, Carolina Merino20, Paloma Vela-Casasempere21, Ignacio Vázquez Gómez22, Jose Alberto Miranda Filloy23, Rafael Benito Melero-Gonzalez24, Clara Garcia Belando25, Giuliano Boselli26, Alina Lucica Boteanu27, Dolly Viviana Fiallo Suárez28, Cristina Corrales Selaya29, ALBERTO MARIANO RUIZ ROMAN30 and Jaime Calvo-Alén31, 1Hospital Universitario Araba, Vitoria, 2Hospital Universitario Alava, Vitoria, Pais Vasco, Spain, 3Hospital de la Santa Creu i Sant Pau, Barcelona, 4C. H. U. A Coruña, C. H. U. A Coruña, 5H. U. Virgen Macarena, H. U. Virgen Macarena, 6Rheumatologist, La Laguna, Spain, 7Rheumatology Department. Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran C, Spain, 8Department of Rheumatology, Hospital Universitario Doctor Negrín, Las Palmas de Gran Canaria, Las Palmas GC, Spain, 9Rheumatology Department, Complejo Asistencial Universitario de León, León, Spain, Leon, Spain, 10Complejo Asistencial Universitario de León, León, Spain, 11Hospital Clínico Universitario de Salamanca, Salamanca, Spain, 12Hospital Clinic de Barcelona, Barcelona, Spain, 13Hospital Universitari Germans Trias i Pujol, Badalona, Spain, 14Althaia Xarxa Assistencial Universitària Manresa, Manresa, Catalonia, Spain, 15Mutua de Terrasa, Barcelona, 16Hospital Vall D'Hebron, Barcelona, Spain, 17Hospital 12 de Octubre, Madrid, 18Resident in Rheumatology, Madrid, Spain, 19University Hospital La Paz, Madrid, Spain, 20Hospital Universitario Puerta de Hierro Majadahonda., Majadahonda (Madrid), Spain, 21Hospital General Universitario Alicante, Alicante, Spain, 22H. U. Dr. Peset, Valencia, 23C. H. U. Lucus Augusti, Lugo, Spain, 24CHU Ourense, O Carballino, Spain, 25H. C. U. Virgen de la Arrixaca, Murcia, 26hospital miguel servet, zaragoza, Aragon, Spain, 27H.U. Ramón y Cajal, Madrid, Spain, 28H. U. de Gran Canaria. Dr. Negrin, H. U. de Gran Canaria, 29Rheumatology, Marques de Valdecilla University Hospital. IDIVAL, Santander, Cantabria, Spain, 30Hospital Universitario Juan Ramón Jiménez, Huelva, Spain, 31Department of Rheumatology, Hospital Araba, Vitoria, Pais Vasco, Spain

    Background/Purpose: VEXAS syndrome is an autoinflammatory disorder caused by a mutation in the UBA1 gene, which leads to a heterogeneous clinical presentation and progressive bone…
  • Abstract Number: 0148 • ACR Convergence 2024

    The Incidence and Prevalence of Sarcoidosis in England

    Katie Bechman1, Kathryn Biddle1, Mark Russell2, Mark Gibson1, maryam adas1, Zijing Yang2, Edward Alveyn1, deepak Nagra2, Sam Norton2, Surinder biring1 and James Galloway3, 1King's College London, London, United Kingdom, 2King's College London, London, England, United Kingdom, 3Centre for Rheumatic Diseases, King's College London, London, United Kingdom

    Background/Purpose: Sarcoidosis is heterogeneous condition, ranging from mild self-limiting disease to severe organ involvement and death. Despite its clinical significance, the epidemiological landscape in England…
  • Abstract Number: 2126 • ACR Convergence 2024

    Analysis of the Evolution of Bone Mineral Density in the Spanish Population: Results of the OsteoSER Study

    Carmen Gomez Vaquero1, Marta Domínguez-Álvaro2, Daniel Seoane-Mato3, Pilar Peris4, Santos Castañeda5, Eduardo Kanterewicz Binstock6, Ramon Mazzucchelli7, Luis Arboleya8, Miguel Bernad9, Antonio Alvarez-Cienfuegos10, Blanca Correa11, Luis-Maria Jimenez-Liñan12, Carmen Mateo-Pascual13, Mª Mercedes Molina del Rio14, Mercedes Retamal-Ortiz15, Aida Fatima Lopez-Laguna16, Ruth Molera-Valero17, Sara Alvar-Pariente18, Antonio Pascual19, Adolfo Arias-Senso20, Nuria Perez-Gutierrez21, Soledad Garcia-Frias22, David Bouza-Alvarez23, Susana Sostres24, Daniel Suarez-Hernandez25, Ana Zamora-Casal26, Cristina Garcia-Ramirez27 and Enrique González-Dávila28, and OsteoSER Project Collaborative Group, 1Hospital Universitari de Bellvitge, 08907 L'Hospitalet, Catalonia, Spain, 2Sociedad Española de Reumatología, Madrid, Spain, 3Sociedad Española de Reumatología, Madrid, Madrid, Spain, 4Rheumatology Department, Hospital Clínic de Barcelona, Barcelona, Spain, 5Hospital Universitario de la Princesa, Madrid, Spain, 6Hospital Universitari de Vic (Consorci Hospitalari de Vic), Barcelona, Spain, 7Hospital Universitario Fundacion Alcorcon, Madrid, Spain, 8Hospital Universitario Central de Asturias, Oviedo, Spain, 9Hospital Universitario La Paz, Madrid, Spain, 10Conselleria de Sanitat/Hospital de la Vega Baja, Orihuela, Comunidad Valenciana, Spain, 11Clínica Sanz y Correa, A Coruña, Spain, 12Hospital Don Benito-Villanueva, Don Benito, Spain, 13Centro de Salud Fuencarral, distrito Fuencarral-El Pardo, Madrid, Spain, 14Centro de Atención Primaria Viladecans Montbaig, Sant Climent de Llobregat, Spain, 15Centro de Salud Don Benito Oeste, Don Benito, Spain, 16Centro de Salud El Molar, El Molar, Spain, 17Centro de Salud Orihuela 1-El Rabaloche, Orihuela, Spain, 18Centro de Salud Malpica, Malpica, Spain, 19Centro de salud Ronda-Norte y Ronda-Sur Santa Bárbara, Ronda, Spain, 20Centro de Salud de Santa Amalia, Santa Amalia, Spain, 21Centro de Atención Primaria Ramona Via i Pros, El Prat de Llobregat, Spain, 22Centro de Salud de Cortes de la Frontera, Cortes de la Frontera, Spain, 23Centro de Salud Elviña Mesoiro, A Coruña, Spain, 24Centro de Atención Primaria Cap 17 de setembre, El Prat de Llobregat, Spain, 25Centro de Salud de Benejuzar, Benezujar, Spain, 26Centro de Salud Os Mallos, A Coruña, Spain, 27Centro de Salud Ronda-Sur Santa Bárbara, Ronda, Spain, 28Departamento de Matemáticas, Estadística e Investigación Operativa, Universidad La Laguna, San Cristobal de La Laguna, Spain

    Background/Purpose: The bone mineral density (BMD) reference data for the Spanish population comes from the study Multicentre Research Project on Osteoporosis (MPRO), concluded in 1989.Our…
  • Abstract Number: 0159 • ACR Convergence 2024

    Prevalence and Potential Factors Associated with Polypharmacy in Individuals with Systemic Lupus Erythematosus

    Jianing Yang1, Jinoos Yazdany2, S. Sam Lim3, Brad Pearce3 and Laura Plantinga4, 1Highland Hospital, AHS, San Leandro, CA, 2UCSF, San Francisco, CA, 3Emory University, Atlanta, GA, 4University of California, San Francisco, San Francisco, CA

    Background/Purpose: Polypharmacy is associated with an increased risk of adverse drug effects and medication nonadherence. However, the prevalence of polypharmacy and the medications and factors…
  • Abstract Number: 2415 • ACR Convergence 2024

    Characterizing the Population with Suspected Lupus Nephritis in Care of a Community Rheumatology Network

    Nehad Soloman1, Jawad Bilal2, Romy Cabacungan3, Scott Milligan4, Andrew Sharobeem5, John Tesser6 and Henry Leher7, 1Arizona Arthritis & Rheumatology Associates, P.C., Glendale, AZ, 2University of Arizona, Tucson, AZ, 3Arizona Arthritis & Rheumatology Associates, P.C., Tucson, AZ, 4Trio Health, Louisville, CO, 5AARA, Peoria, AZ, 6Arizona Arthritis & Rheumatology Associates, Phoenix, AZ, 7Aurinia Pharma, Stowe, VT

    Background/Purpose: Lupus nephritis (LN) has been estimated to develop in up to 40% of all patients with systemic lupus erythematosus (SLE), with higher rates in…
  • Abstract Number: 0475 • ACR Convergence 2023

    Prevalence of Endometriosis and Polycystic Ovarian Syndrome in Patients with Rheumatic Diseases in the United States

    Sabahat Usmani1, Catherine Lavallee2, Maria Antonelli3 and Cuoghi Edens4, 1Weiss Memorial Hospital, Chicago, IL, 2Virginia Tech Carilion School of Medicine, Roanoke, VA, 3MetroHealth System, Cleveland, OH, 4University of Chicago, Chicago, IL

    Background/Purpose: Endometriosis (ENDO) and Polycystic Ovarian Syndrome (PCOS) are underdiagnosed, often debilitating conditions with unknown etiologies that, like rheumatic diseases, affect reproductive-aged women. Recent studies…
  • Abstract Number: 0543 • ACR Convergence 2023

    Sensitivity of the 2019 European Alliance of Associations for Rheumatology /American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus in a Population-based Cohort; A Study Set in Norway 2000-2015

    Hilde Haukeland1, Sigrid Reppe Moe1, Cathrine Brunborg2, Antonela Botea3, Nenad Damjanic4, Gro Wivestad5, Heidi Øvreås6, Thea Bøe7, Torhild Garen1, Anniken Orre8, Helga Sanner9, Øyvind Molberg10 and Karoline Lerang9, 1Oslo University Hospital, Department of Rheumatology, Oslo, Norway, 2Oslo Centre for Biostatistics and Epidemiology, Research Support Services, Oslo University Hospital - Rikshospitalet, Oslo, Norway, 3Betanien Hospital, Department of Rheumatology, Skien, Norway, 4Ostfold Hospital Trust, Department of Rheumatology,, Grålum, Norway, 5Hospital of Southern Norway Trust, Division of Rheumatology, Department of Medicine, Kristiansand, Norway, 6Lillehammer Hospital for Rheumatic Diseases, Department of Rheumatology, Lillehammer, Norway, 7Vestfold Hospital Trust, Department of Internal Medicine, Tønsberg, Norway, 8Vestre Viken Hospital Trust, Department of Rheumatology, Drammen, Norway, 9Oslo University Hospital, Department of Rheumatology, Nydalen, Norway, 10University of Oslo, Institute of Clinical Medicine, Oslo, Norway

    Background/Purpose: To diagnose Systemic Lupus Erythematosus (SLE), one must understand the phenotype specter and interpret clinical, serological, radiological, and histopathological data, as well as exclude…
  • Abstract Number: 0751 • ACR Convergence 2023

    Recombinant Zoster Vaccination Among U.S. Veterans Receiving Immunosuppressive Medications 2017-2023

    Sharon Abada1, Jing Li1, Gary Tarasovsky2, Cherish Wilson3, Jinoos Yazdany1, Mary Whooley1 and Gabriela Schmajuk3, 1University of California San Francisco, San Francisco, CA, 2San Francisco VA, San Francisco, CA, 3UCSF / SFVA, San Francisco, CA

    Background/Purpose: Patients receiving immunosuppressive therapies are known to have a higher risk of herpes zoster and subsequent complications compared to the general population. The recombinant…
  • Abstract Number: 0977 • ACR Convergence 2023

    Prevalence of Arthritis in the United States: National Estimates from a Population-based Study

    Sumanth Chandrupatla1, Kranti Rumalla2 and Jasvinder Singh1, 1University of Alabama at Birmingham, Birmingham, AL, 2Northwestern School of Medicine, Chicago, IL

    Background/Purpose: Arthritis is the number 1 cause of disability among U.S. adults and reported to cost > $300 billion in direct and indirect costs in…
  • Abstract Number: 1166 • ACR Convergence 2023

    Patients with COVID-19 and Polymyositis Inpatient Outcomes and Hospital Cost: Nationwide Inpatient Sample 2020

    Emily He1 and Vaneet Sandhu2, 1Loma Linda University Health, Loma Linda, CA, 2Loma Linda University, Loma Linda, CA

    Background/Purpose: During the COVID-19 pandemic, there were growing concerns regarding the impact of SARS-CoV-2 on not only patients with rheumatic diseases but also the national…
  • Abstract Number: 1821 • ACR Convergence 2023

    The “Weekend Effect” and Rheumatological Association in Patients with Diffuse Alveolar Haemorrhage

    Shobhit Piplani1, Shreya Gulati2, Vladimir Jelic1, Asad Ahmed3, Sung Mi Yoon1, Donclair Brown1, Miroslav Radulovic1 and Beverly Johnson4, 1Jacobi Medical Center/North Central Bronx, Albert Einstein College of Medicine, NYC Health and Hospitals, Bronx, NY, 2Jawahar lal Nehru Medical College, New York, NY, 3SUNY Downstate, Brooklyn, NY, 4Albert Einstein College of Medicine, Jacobi/NCB, New York, NY

    Background/Purpose: Diffuse alveolar hemorrhage (DAH) is a life-threatening pulmonary complication commonly associated with autoimmune disorders. Limited treatment options are available for DAH, and time to…
  • Abstract Number: 1918 • ACR Convergence 2023

    Nationwide Analysis of Predictors of Sarcoid Inpatient Mortality

    Michael Manansala1, Faria Sami2, Shilpa Arora3 and Augustine Manadan1, 1Rush University Medical Center, Chicago, IL, 2John H. Stroger Jr. Hospital of Cook County, Chicago, IL, 3Cook County Hospital, Chicago, IL

    Background/Purpose: Sarcoidosis is multisystem autoimmune disease characterized by noncaseating granulomas which can result in significant morbidity and mortality. This study aims to identify variables associated…
  • Abstract Number: 1947 • ACR Convergence 2023

    National Incidence, Prevalence & Mortality in Idiopathic Inflammatory Myopathies & Associated Interstitial Lung Disease in England

    Jennifer Hannah1, Fiona Pearce2, Myron Odingo2, Megan Rutter2, Jeanette Aston3, Jennifer Lai3, Matthew Grainge2, Sean Mcphail3, Peter Lanyon2, Mary Bythell3, James Galloway4 and Patrick Gordon5, 1King's College London, London, United Kingdom, 2University of Nottingham, Nottingham, United Kingdom, 3National Disease Registration Service, Leeds, United Kingdom, 4King's College London, London, United Kingdom, 5NHS, London, United Kingdom

    Background/Purpose: Ethnicity, sex, age & socioeconomic deprivation can all lead to health inequity. Impact of these factors in epidemiology of Idiopathic Inflammatory Myopathies (IIM) has…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 10
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology